Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 5 of 5 for “"Cytosine Base Editor"”.
-
The Design and In-Vitro Validation of Therapeutic CRISPR Base Editing and AAV-9 Gene Therapy for the Treatment of Classic Galactosemia
… an AAV-9 gene replacement therapy, and a CRISPR cytosine base editor therapy. We observed that our AAV-9 expression plasmid for human GALT enzyme successfully restored enzyme levels in the substitution in Q188R homozygous patient fibroblast cells as shown through western blotting. However, …
-
MATERIAL AND BIOLOGICAL ENGINEERING OF LIPID NANOPARTICLE AND CRISPR GENE EDITOR SYSTEM FOR IN VIVO PRECISION MEDICINE
… precision gene editing technologies such as base editing and prime editing. Majority of these coagulation factors are synthesized in hepatocytes, thereby making the liver an ideal target for therapeutic intervention. Lipid nanoparticles (LNPs) have emerged as a versatile and clinically …
-
Genome Editing to Study and Precisely Model Complex Genetic Disorders
… models for drug screening, engineering improved base editors for precise genome modification, and applying base editing with lentiviral delivery to validate candidate regulatory variants in IBD-associated loci. The mutation-specific CF cell models cover different classes/severity of CF and enable …
-
Development and utilization of genome editing tools in maize, sorghum and rice
… -C2c1(Cas12b), -C2c2(Cas13a) and CRISPR derived base editor (Adenine and Cytosine Base Editor) are state-of-the-art targeted mutagenesis toolkits for basic and applied research. Users have more options to edit, delete, insert, inactivate, activate, repress, label, methylate and acetylate the …
-
Using Upd-Seq To Understand Genome-Wide Targeting By The Human Aid/apobec3 Enzymes
AID/APOBEC3 group of cytosine deaminases are central to our innate and adaptive immunity. However, the misregulation of these enzymes may lead to mutations, double-strand breaks, and translocations, that can result in cancer or drug-resistant tumors. Due to the limitations of the current sequencing …